Related Experiment Videos

The frequency of uniparental disomy in Prader-Willi syndrome. Implications for molecular diagnosis

M J Mascari1, W Gottlieb, P K Rogan

  • 1Department of Pediatrics, Milton S. Hershey Medical Center, College of Medicine, Pennsylvania State University, Hershey 17033.

Insights

Maternal uniparental disomy, inheriting both copies of chromosome 15 from the mother, causes Prader-Willi syndrome in about 20% of cases. Molecular and cytogenetic tests identify the genetic cause in most patients.

Area of Science:

  • Genetics
  • Molecular Biology
  • Pediatrics

Background:

  • Prader-Willi syndrome (PWS) is a complex genetic disorder affecting infants and children, presenting with hypotonia, obesity, hypogonadism, and intellectual disability.
  • Clinical diagnosis of PWS can be challenging in early childhood.
  • Genetic basis typically involves a deletion in the paternally derived chromosome 15 (15q11q13), present in about two-thirds of patients.

Purpose of the Study:

  • To investigate the frequency of maternal uniparental disomy (UPD) in Prader-Willi syndrome patients lacking a detectable cytogenetic deletion.
  • To utilize molecular genetic techniques to identify alternative genetic causes of PWS.

Main Methods:

  • Molecular analyses were performed on DNA markers within the 15q11q13 region and other parts of chromosome 15.
  • The study included 30 PWS patients without visible deletions and their parents.
  • Three PWS patients with cytogenetic deletions were included as controls.

Main Results:

  • Maternal uniparental disomy for chromosome 15 was identified in 60% (18/30) of PWS patients without cytogenetic deletions, with an association with advanced maternal age.
  • Large molecular deletions were found in 27% (8/30) of these patients.
  • Normal biparental inheritance was observed in 13% (4/30) of patients, with three exhibiting atypical clinical features.

Conclusions:

  • Maternal uniparental disomy accounts for approximately 20% of all Prader-Willi syndrome cases.
  • Combining cytogenetic and molecular techniques allows for the identification of the genetic basis in up to 95% of PWS patients.
Abstract

Related Concept Videos